Literature DB >> 22532819

Exercise tolerance in genetic cardiac disorders.

Wilfried Kindermann.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22532819      PMCID： PMC3334718          DOI： 10.3238/arztebl.2012.0236a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

Review 1.  Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.

Authors:  Antonio Pelliccia; Robert Fagard; Hans Halvor Bjørnstad; Aris Anastassakis; Eloisa Arbustini; Deodato Assanelli; Alessandro Biffi; Mats Borjesson; François Carrè; Domenico Corrado; Pietro Delise; Uwe Dorwarth; Asle Hirth; Hein Heidbuchel; Ellen Hoffmann; Klaus P Mellwig; Nicole Panhuyzen-Goedkoop; Angela Pisani; Erik E Solberg; Frank van-Buuren; Luc Vanhees; Carina Blomstrom-Lundqvist; Asterios Deligiannis; Dorian Dugmore; Michael Glikson; Per Ivar Hoff; Andreas Hoffmann; Erik Hoffmann; Dieter Horstkotte; Jan Erik Nordrehaug; Jan Oudhof; William J McKenna; Maria Penco; Silvia Priori; Tony Reybrouck; Jeff Senden; Antonio Spataro; Gaetano Thiene
Journal:  Eur Heart J       Date:  2005-05-27       Impact factor: 29.983

Review 2.  Inherited cardiac arrhythmias: diagnosis, treatment, and prevention.

Authors:  Britt-Maria Beckmann; Arne Pfeufer; Stefan Kääb
Journal:  Dtsch Arztebl Int       Date:  2011-09-16       Impact factor: 5.594

3.  Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.

Authors:  Antonio Pelliccia; Douglas P Zipes; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2008-12-09       Impact factor: 24.094
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.